Literature DB >> 24295651

Desoxyrhapontigenin, a potent anti-inflammatory phytochemical, inhibits LPS-induced inflammatory responses via suppressing NF-κB and MAPK pathways in RAW 264.7 cells.

Ran Joo Choi1, Jaemoo Chun1, Salman Khan1, Yeong Shik Kim2.   

Abstract

This study investigates the anti-inflammatory effects of a stilbene compound, desoxyrhapontigenin, which was isolated from Rheum undulatum. To determine the anti-inflammatory effects of this compound, lipopolysaccharide (LPS)-induced RAW 264.7 macrophages were treated with different concentrations of six stilbene derivatives. The results indicated that compared with other stilbene compounds, desoxyrhapontigenin (at 10, 30 and 50μM concentrations) significantly inhibited nitric oxide (NO) production, nuclear factor kappa B (NF-κB) activation, the protein expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression. Therefore, the anti-inflammatory mechanism of desoxyrhapontigenin was investigated in detail. The results of this investigation demonstrated that desoxyrhapontigenin suppressed not only LPS-stimulated pro-inflammatory cytokine secretions, including the secretions of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), but also PGE2 release. As assayed by electrophoretic mobility shift assays (EMSAs), desoxyrhapontigenin also produced the dose-dependent inhibition of the LPS-induced activation of NF-κB and AP-1. Moreover, desoxyrhapontigenin inhibited the protein expression of myeloid differentiation primary response gene 88 (MyD88), IκB kinase (IKK) phosphorylation and the degradation of IκBα. Activations of p-JNK1 and p-Akt were also significantly inhibited, and phosphorylation of p38 and ERK was down-regulated. A further study revealed that desoxyrhapontigenin (5 and 25mg/kg, i.p.) reduced paw swelling in carrageenan-induced acute inflammation model in vivo. On the whole, these results indicate that desoxyrhapontigenin showed anti-inflammatory properties by the inhibition of iNOS and COX-2 expression via the down-regulation of the MAPK signaling pathways and the inhibition of NF-κB and Akt activation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Desoxyrhapontigenin; Inflammation; MAPK; NF-κB; Stilbenes

Mesh:

Substances:

Year:  2013        PMID: 24295651     DOI: 10.1016/j.intimp.2013.11.022

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  13 in total

1.  A new cationic palladium(II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models.

Authors:  Muhammad Naveed; Shahan Zeb Khan; Sara Zeeshan; Adnan Khan; Bushra Shal; Ayesha Atiq; Hussain Ali; Rahim Ullah; Salman Khan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-09       Impact factor: 3.000

2.  Hydroxysafflor yellow A inhibits lipopolysaccharide-induced proliferation and migration of vascular smooth muscle cells via Toll-like receptor-4 pathway.

Authors:  Guoshuai Yang; Xiaoyan Zhou; Tao Chen; Yidong Deng; Dan Yu; Suyue Pan; Yanmin Song
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 3.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

4.  Inhibition of NF-κB signaling and HSP70/HSP90 proteins by newly synthesized hydrazide derivatives in arthritis model.

Authors:  Ashraf Ullah Khan; Amna Khan; Adnan Khan; Bushra Shal; Abdul Aziz; Muhammad Naeem Ahmed; Salman Ul Islam; Hussain Ali; Adeeb Shehzad; Salman Khan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-13       Impact factor: 3.000

5.  Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences.

Authors:  Kalpesh R Patil; Purusottam Mohapatra; Harun M Patel; Sameer N Goyal; Shreesh Ojha; Chanakya N Kundu; Chandragouda R Patil
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

6.  Anti-inflammatory effects of proanthocyanidin-rich red rice extract via suppression of MAPK, AP-1 and NF-κB pathways in Raw 264.7 macrophages.

Authors:  Pornngarm Limtrakul; Supachai Yodkeeree; Pornsiri Pitchakarn; Wanisa Punfa
Journal:  Nutr Res Pract       Date:  2016-04-01       Impact factor: 1.926

7.  Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.

Authors:  Xichun Pan; Bin Li; Mei Kuang; Xin Liu; Yanyan Cen; Rongxin Qin; Guofu Ding; Jiang Zheng; Hong Zhou
Journal:  Int J Mol Sci       Date:  2016-02-22       Impact factor: 5.923

8.  Deoxyrhapontigenin, a Natural Stilbene Derivative Isolated From Rheum undulatum L. Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Human Breast Cancer Cells.

Authors:  Thamizhiniyan Venkatesan; Min-Ji Jeong; Young-Woong Choi; Eun-Jin Park; Samy Korany El-Desouky; Young-Kyoon Kim
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

9.  Desoxyrhapontigenin up-regulates Nrf2-mediated heme oxygenase-1 expression in macrophages and inflammatory lung injury.

Authors:  Ran Joo Choi; Mao-Sheng Cheng; Yeong Shik Kim
Journal:  Redox Biol       Date:  2014-02-18       Impact factor: 11.799

10.  Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid, and Quercetin from Radix Sanguisorbae.

Authors:  Chang-Seob Seo; Soo-Jin Jeong; Sae-Rom Yoo; Na-Ri Lee; Hyeun-Kyoo Shin
Journal:  Pharmacogn Mag       Date:  2016 Apr-Jun       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.